|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
1738736482 |
| 003 |
DE-627 |
| 005 |
20230426122302.0 |
| 007 |
tu |
| 008 |
201116s2021 ne ||||| 00| ||eng c |
| 020 |
|
|
|a 9780128240038
|c : pbk. : (£76.95)
|9 978-0-12-824003-8
|
| 035 |
|
|
|a (DE-627)1738736482
|
| 035 |
|
|
|a (DE-599)KXP1738736482
|
| 035 |
|
|
|a (OCoLC)1226373651
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-NL
|c XA-GB
|c XD-US
|
| 082 |
0 |
|
|a 616.2414
|
| 084 |
|
|
|a YD 8600
|q DE-16
|2 rvk
|0 (DE-625)rvk/164057:12905
|
| 084 |
|
|
|a 44.75
|2 bkl
|
| 100 |
1 |
|
|a Qu, Jieming
|d 1964-
|e verfasserin
|0 (DE-588)1232278823
|0 (DE-627)1756046174
|4 aut
|
| 245 |
1 |
0 |
|a COVID-19
|b the essentials of prevention and treatment
|c Jie-Ming Qu, Bin Cao, Rong-Chang Chen
|
| 264 |
|
1 |
|a Amsterdam
|a Oxford
|a Cambridge, MA
|b Elsevier
|c [2021]
|
| 264 |
|
4 |
|c © 2021
|
| 300 |
|
|
|a x, 103 Seiten
|b Illustrationen (teilweise farbig)
|c 23 cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 336 |
|
|
|a unbewegtes Bild
|b sti
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 650 |
|
0 |
|a COVID-19 (Disease)
|x Treatment
|
| 650 |
|
0 |
|a COVID-19 (Disease)
|x Prevention
|
| 650 |
0 |
7 |
|0 (DE-588)4059798-2
|0 (DE-627)106142216
|0 (DE-576)209132310
|a Therapie
|2 gnd
|
| 650 |
0 |
7 |
|0 (DE-588)1206347392
|0 (DE-627)1692339907
|a COVID-19
|2 gnd
|
| 650 |
0 |
7 |
|0 (DE-588)4737034-8
|0 (DE-627)365953423
|0 (DE-576)215891244
|a Pandemie
|2 gnd
|
| 650 |
0 |
7 |
|0 (DE-588)4012040-5
|0 (DE-627)10635020X
|0 (DE-576)208896597
|a Diagnose
|2 gnd
|
| 700 |
1 |
|
|a Cao, Bin
|e verfasserin
|0 (DE-588)1232280186
|0 (DE-627)1756047839
|4 aut
|
| 700 |
1 |
|
|a Chen, Rongchang
|e verfasserin
|0 (DE-588)1232280666
|0 (DE-627)1756048835
|4 aut
|
| 776 |
0 |
8 |
|i Erscheint auch als
|n Online-Ausgabe
|a Qu, Jieming, 1964 -
|t Covid-19
|d San Diego : Elsevier, 2020
|h 1 online resource (116 pages)
|w (DE-627)1738820920
|z 9780128242513
|
| 912 |
|
|
|a GBV_ILN_101
|
| 912 |
|
|
|a ISIL_DE-Ma14
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_2011
|
| 912 |
|
|
|a ISIL_DE-16
|
| 912 |
|
|
|a GBV_ILN_2141
|
| 912 |
|
|
|a ISIL_DE-16-300
|
| 936 |
r |
v |
|a YD 8600
|b Allgemeines
|k Medizin
|k Infektionskrankheiten
|k Viruskrankheiten
|k Coronaviruskrankheiten (SARS, MERS, COVID-19 u.a.)
|k Allgemeines
|0 (DE-627)1783495294
|0 (DE-625)rvk/164057:12905
|
| 936 |
b |
k |
|a 44.75
|j Infektionskrankheiten
|j parasitäre Krankheiten
|x Medizin
|0 (DE-627)106415948
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 616.2414
|
| 980 |
|
|
|2 101
|1 01
|x 3101
|b 418472289X
|c 00
|f 0521.06
|d ZB -0521-339
|e u
|j --%%--
|h ACQ
|y z
|z 13-10-22
|
| 980 |
|
|
|2 2011
|1 01
|x DE-16
|b 3894958375
|c 00
|f --%%--
|d UBN/YD 8600 Q1
|e --%%--
|j --%%--
|y l01
|z 26-03-21
|
| 980 |
|
|
|2 2141
|1 01
|x DE-16-300
|b 3806672679
|c 00
|f 261
|d U 1a
|e --%%--
|j --%%--
|c 01
|f --%%--
|d T 2c
|e --%%--
|j --%%--
|y l01
|z 18-11-20
|
| 983 |
|
|
|2 101
|1 00
|x DE-Ma14
|8 00
|a 0521.06
|
| 984 |
|
|
|2 101
|1 01
|x 3101
|a MA14$1060163
|
| 984 |
|
|
|2 2011
|1 01
|x DE-16
|a 106338461
|
| 984 |
|
|
|2 2141
|1 01
|x DE-16-300
|a 590696835
|
| 985 |
|
|
|2 2141
|1 01
|x DE-16-300
|a m/2000282
|
| 995 |
|
|
|2 101
|1 01
|x 3101
|a ACQ
|
